Oncologist Claims To Cure Late-Stage Cancer With These Repurposed Drugs

Leave a CommentOncologist Claims To Cure Late-Stage Cancer With These Repurposed DrugsBreakthroughs, Health

Dr. William Makis is a Canadian Nuclear Medicine Radiologist and Oncologist known for his work in cancer treatment, particularly with alternative and repurposed drugs like Ivermectin, Fenbendazole, and Mebendazole. Here’s an overview of his background and his notable protocols for cancer treatment:

Background:

  • Education and Career: Dr. Makis obtained his Immunology degree from the University of Toronto and graduated from McGill University School of Medicine in 2005. He specializes in Nuclear Medicine Radiology and Oncology.
  • Experience: He has been involved in diagnosing over 10,000 cancer patients and has managed one of the largest Targeted Radionuclide Therapy Cancer Clinics in North America. His research focuses on Targeted Radionuclide Therapy and Theranostics, particularly with agents like Lutathera (177Lu-DOTATATE) for neuroendocrine tumors .
  • Publications: Dr. Makis has over 100 peer-reviewed publications, contributing significantly to the field of nuclear medicine and oncology.

Cancer Treatment Protocols:

  1. Ivermectin for Cancer:
    • Mechanism: Ivermectin has been studied for its potential anti-cancer properties, notably for its ability to impact cancer stem cells and induce apoptosis in cancer cells .
    • Protocols: Dr. Makis has proposed experimental protocols for using Ivermectin, particularly for aggressive cancers like “turbo cancers” potentially linked to mRNA vaccines. These protocols include:
      • Starting Dose: For most cancers, including those he labels as mRNA vaccine-induced turbo cancers, he suggests a starting dose of Ivermectin.
      • Aggressive Cancers: For rare and very aggressive types, higher doses or different regimens might be suggested, which could involve combining with other treatments .
  2. Fenbendazole and Mebendazole:
    • Mechanism: These anti-parasitic drugs have been explored for their potential in cancer treatment due to their abilities to inhibit cancer cell growth, induce apoptosis, and potentially affect cancer stem cells.
    • Protocol:
      • Dosing: Specific doses of Fenbendazole and Mebendazole are recommended based on the patient’s cancer type, stage, and weight. Often, these are combined with dietary changes like a ketogenic diet to maximize therapeutic benefit by starving cancer cells of glucose .
  3. General Approach:
    • Dr. Makis advocates for patient empowerment through awareness of alternative treatments. His protocols often emphasize:
      • Dietary Interventions: Including fasting or ketogenic diets to alter cancer cell metabolism.
      • Combination Therapy: Using these drugs in conjunction with conventional or other alternative therapies for potentially synergistic effects.

Claimed successes

Here are some brief success stories related to Dr. William Makis’s protocols for cancer treatment, based on information from online sources:

  1. Stage 4 Renal Carcinoma:
    • A patient with Stage 4 Renal Carcinoma showed improvement after using Ivermectin and Fenbendazole, especially when conventional treatments from Alberta Health Services (AHS) had failed.
  2. Ovarian Cancer:
    • A patient with advanced ovarian cancer experienced a 30% drop in CA125 cancer marker levels after only three weeks on a high-dose regimen of Ivermectin combined with Mebendazole.
  3. Stage 4 Pancreatic Cancer:
    • A patient diagnosed with stage 4 pancreatic cancer in August 2023, given 3-6 months to live, started the Fenbendazole Protocol. By November 2023, the cancer had not grown or spread, and by January 2024, the cancer marker had dropped significantly from over 100,000 to 18,000.
  4. Stage 4 Breast Cancer:
    • Denise Pane, after being diagnosed with metastatic breast cancer that had spread to her bones, used Fenbendazole and reported being cancer-free.
  5. Colorectal Cancer with Liver Metastases:
    • A patient in his 60s with Stage 4 colorectal cancer and liver metastases saw a decrease in CEA levels and disappearance of chemotherapy side effects after starting Ivermectin and Fenbendazole.
  6. General Improvement in Cancer Patients:
    • During an event titled “An Injection of Truth,” several individuals approached Dr. Makis to share that their cancers were shrinking after following his high-dose Ivermectin, Fenbendazole, or Mebendazole protocols.

These stories primarily revolve around the use of Ivermectin, Fenbendazole, and Mebendazole, which are central to Dr. Makis’s approach.

Warning

Remember, these are anecdotal reports, and while they provide hope and suggest potential benefits, they should be considered within the context of broader, more rigorous clinical research.

His work has garnered attention for its focus on repurposed drugs, which are often less costly and potentially less toxic than traditional chemotherapy. But, it’s important to note that while there is interest and some anecdotal evidence, much of this is still considered experimental or under research. Patients interested in these treatments should consult with their healthcare providers for a comprehensive approach tailored to their specific condition.